150 related articles for article (PubMed ID: 18076975)
1. A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients.
Dronne MA; Grenier E; Chapuisat G; Hommel M; Boissel JP
Prog Biophys Mol Biol; 2008 May; 97(1):60-78. PubMed ID: 18076975
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based model of acute ischemic stroke.
Duval V; Chabaud S; Girard P; Cucherat M; Hommel M; Boissel JP
J Cereb Blood Flow Metab; 2002 Aug; 22(8):1010-8. PubMed ID: 12172387
[TBL] [Abstract][Full Text] [Related]
3. In silico study of the influence of intensity and duration of blood flow reduction on cell death through necrosis or apoptosis during acute ischemic stroke.
Chapuisat G; Dronne MA; Grenier E; Hommel M; Boissel JP
Acta Biotheor; 2010 Sep; 58(2-3):171-90. PubMed ID: 20665072
[TBL] [Abstract][Full Text] [Related]
4. [Neuroprotection in brain ischemia--doubts and hopes].
Zádor Z; Benyó Z; Lacza Z; Hortobágyi T; Harkány T; Hortobágyi T
Ideggyogy Sz; 2004 Mar; 57(3-4):81-93. PubMed ID: 15133909
[TBL] [Abstract][Full Text] [Related]
5. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.
Durukan A; Tatlisumak T
Pharmacol Biochem Behav; 2007 May; 87(1):179-97. PubMed ID: 17521716
[TBL] [Abstract][Full Text] [Related]
6. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
Candelario-Jalil E
Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
[TBL] [Abstract][Full Text] [Related]
7. A global phenomenological model of ischemic stroke with stress on spreading depressions.
Chapuisat G; Dronne MA; Grenier E; Hommel M; Gilquin H; Boissel JP
Prog Biophys Mol Biol; 2008 May; 97(1):4-27. PubMed ID: 18063019
[TBL] [Abstract][Full Text] [Related]
8. Recanalization and reperfusion therapies for acute ischemic stroke.
Molina CA; Alvarez-Sabín J
Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
[TBL] [Abstract][Full Text] [Related]
9. [Neuroprotective agents].
Dávalos A
Neurologia; 1999; 14 Suppl 4():49-53. PubMed ID: 10613033
[TBL] [Abstract][Full Text] [Related]
10. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
13. Treating acute ischemic stroke.
Fisher M; Bastan B
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on neuroprotective stroke therapy.
Schäbitz WR; Fisher M
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1271-6. PubMed ID: 17073800
[TBL] [Abstract][Full Text] [Related]
15. Ischemic stroke intervention requires mixed cellular protection of the penumbra.
Barone FC
Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878
[TBL] [Abstract][Full Text] [Related]
16. [Ischemic preconditioning in the brain].
Nagy K; Domoki F; Bari F
Ideggyogy Sz; 2005 Sep; 58(9-10):305-13. PubMed ID: 16252891
[TBL] [Abstract][Full Text] [Related]
17. Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke?
Gibson CL; Coomber B; Rathbone J
Neuroscientist; 2009 Aug; 15(4):324-32. PubMed ID: 19359672
[TBL] [Abstract][Full Text] [Related]
18. [Overview of the recent clinical trials in severe head injury and analysis of their therapeutic failure].
Boto GR; Gómez PA; De la Cruz J; Lobato RD
Neurocirugia (Astur); 2005 Feb; 16(1):39-49. PubMed ID: 15756410
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of cerebral ischemia.
Ducruet AF; Grobelny BT; Zacharia BE; Hickman ZL; Yeh ML; Connolly ES
Expert Opin Pharmacother; 2009 Aug; 10(12):1895-906. PubMed ID: 19514865
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
